ABSTRACT
Lactococcus lactis subsp. lactis G50 is a strain with immunostimulating activity, isolated from Napier grass (Pennisetum purpureum). We determined the complete genome sequence of this strain using the PacBio RS II platform. The single circular chromosome consists of 2,346,663 bp, with 35.03% G+C content and no plasmids.
GENOME ANNOUNCEMENT
Strains of Lactococcus lactis are widely used as starters for manufacturing fermented dairy products and fermented vegetables and are also found in various natural environments (1, 2). Because L. lactis is not a natural inhabitant of the mammalian gastrointestinal tract, it had not generally been regarded as a probiotic. Several natural isolates with beneficial health properties, however, have been described (3–5), and some strains are able to survive in the gastrointestinal tract (6–8). We previously investigated the potential use of L. lactis strains as probiotics (7, 9).
L. lactis subsp. lactis G50 was isolated from Napier grass (Pennisetum purpureum Schumach). Among 15 L. lactis strains, G50 induces the highest production of cytokines (interleukin 12 [IL-12], IL-6, and tumor necrosis factor α [TNF-α]) in the macrophage-like cell line J774.1 (10). Heat-treated G50 loses the ability to induce TNF-α in J774.1 (11). In vivo, oral administration of live G50 cells reduces the total IgE antibody production in ovomucoid-sensitized BALB/c mice (10). Long-term oral administration of heat-treated G50 cells to senescence-accelerated mouse prone 6 (SAMP6) does not suppress senescence-associated changes. However, fecal IgA levels of G50-fed mice (3-month-old SAMP6 mice given G50 cells for 2 months) were higher than those of control mice, and the intestinal growth of H2S-producing bacteria was suppressed in G50-fed mice (12).
Genomic information is key to clarifying the potential functions of the strain. To identify potential genetic determinants specifying the properties of strain G50, we determined the complete genome sequence using single-molecule real-time (SMRT) technology (13). SMRT technology offers advantages such as long read lengths, high consensus accuracy, and a low degree of bias and is a powerful tool for sequencing complete bacterial genomes with highly repetitive sequences (14, 15).
The genomic DNA was purified at the early log phase using a PowerClean DNA cleanup kit (Mo Bio Laboratories, Carlsbad, CA), followed by 20-kb library construction for P6-C4 chemistry with shearing (15). Two SMRT cells (each a 240-min movie) were used for sequencing on the PacBio RS II platform (Pacific Biosciences, Menlo Park, CA). De novo assembly was performed using the Hierarchical Genome Assembly Process 2 workflow (16). A single circular contig representing one chromosome (2,346,663 bp, G+C content of 35.03%, and 925× coverage) was obtained. No plasmid was detected. PacBio RS II sequencing produced 654,840 reads, with an average length of 4,305 bp, a maximum length of 49,160 bp, and uniform coverage.
The complete genome sequence of Lactococcus lactis subsp. lactis G50 will help to elucidate the immunostimulating mechanism and will provide insight into the diversity among Lactococcus lactis strains.
Accession number(s).
The complete genome sequence of Lactococcus lactis subsp. lactis G50 has been deposited in DDBJ/ENA/GenBank under the accession number CP025500.
ACKNOWLEDGMENTS
This work was supported by the Okinawa Prefectural Government (to all authors) and by JSPS KAKENHI grant 17K07741 (to C.S.).
K. Nakano, M. Minami, M. Shinzato, M. Shimoji, N. Ashimine, A. Shiroma, S. Ohki, T. Nakanishi, H. Tamotsu, K. Teruya, K. Satou, N. Moriya, M. Kobayashi, T. Hagi, M. Nomura, C. Suzuki, and T. Hirano have no conflicts of interest. Takanashi Milk Products Co., Ltd. and NARO hold a patent in Japan on the use of G50 as an anti-allergic agent (patent P4308481). NARO holds a patent in Japan on the use of G50 as lactic acid bacteria belonging to the genus Lactococcus useful for immunoactivation (patent P3671212). H. Kimoto-Nira is the inventor of both patents.
Footnotes
Citation Nakano K, Minami M, Shinzato M, Shimoji M, Ashimine N, Shiroma A, Ohki S, Nakanishi T, Tamotsu H, Teruya K, Satou K, Moriya N, Kimoto-Nira H, Kobayashi M, Hagi T, Nomura M, Suzuki C, Hirano T. 2018. Complete genome sequence of Lactococcus lactis subsp. lactis G50 with immunostimulating activity, isolated from Napier grass. Genome Announc 6:e00069-18. https://doi.org/10.1128/genomeA.00069-18.
REFERENCES
- 1.Cavanagh D, Fitzgerald GF, McAuliffe O. 2015. From field to fermentation: the origins of Lactococcus lactis and its domestication to the dairy environment. Food Microbiol 47:45–61. doi: 10.1016/j.fm.2014.11.001. [DOI] [PubMed] [Google Scholar]
- 2.Kok J, van Gijtenbeek LA, de Jong A, van der Meulen SB, Solopova A, Kuipers OP. 2017. The evolution of gene regulation research in Lactococcus lactis. FEMS Microbiol Rev 41:S220–S243. doi: 10.1093/femsre/fux028. [DOI] [PubMed] [Google Scholar]
- 3.Nishitani Y, Tanoue T, Yamada K, Ishida T, Yoshida M, Azuma T, Mizuno M. 2009. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice. Int Immunopharmacol 9:1444–1451. doi: 10.1016/j.intimp.2009.08.018. [DOI] [PubMed] [Google Scholar]
- 4.Ballal SA, Veiga P, Fenn K, Michaud M, Kim JH, Gallini CA, Glickman JN, Quéré G, Garault P, Béal C, Derrien M, Courtin P, Kulakauskas S, Chapot-Chartier M-P, van Hylckama Vlieg J, Garrett WS. 2015. Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons. Proc Natl Acad Sci U S A 112:7803–7808. doi: 10.1073/pnas.1501897112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kimoto-Nira H, Suzuki C, Kobayashi M, Sasaki K, Kurisaki J, Mizumachi K. 2007. Anti-ageing effect of a lactococcal strain: analysis using senescence-accelerated mice. Br J Nutr 98:1178–1186. doi: 10.1017/S0007114507787469. [DOI] [PubMed] [Google Scholar]
- 6.Kimoto H, Nomura M, Kobayashi M, Mizumachi K, Okamoto T. 2003. Survival of lactococci during passage through mouse digestive tract. Can J Microbiol 49:707–711. doi: 10.1139/w03-092. [DOI] [PubMed] [Google Scholar]
- 7.Suzuki C, Kimoto-Nira H, Kobayashi M, Nomura M, Sasaki K, Yoshida A, Aoki R, Mizumachi K. 2013. Immunomodulatory effects of Lactococcus lactis strains. JARQ 47:249–255. doi: 10.6090/jarq.47.249. [DOI] [Google Scholar]
- 8.Kimoto-Nira H, Suzuki C, Sasaki K, Kobayashi M, Mizumachi K. 2010. Survival of a Lactococcus lactis strain varies with its carbohydrate preference under in vitro conditions simulated gastrointestinal tract. Int J Food Microbiol 143:226–229. doi: 10.1016/j.ijfoodmicro.2010.07.033. [DOI] [PubMed] [Google Scholar]
- 9.Kimoto-Nira H, Mizumachi K, Nomura M, Kobayashi M, Fujita Y, Okamoto T, Suzuki I, Tsuji MN, Kurisaki J, Ohmomo S. 2007. Lactococcus sp. as potential probiotic lactic acid bacteria. JARQ 41:181–189. doi: 10.6090/jarq.41.181. [DOI] [Google Scholar]
- 10.Kimoto H, Mizumachi K, Okamoto T, Kurisaki J. 2004. New Lactococcus strain with immunomodulatory activity: enhancement of Th1-type immune response. Microbiol Immunol 48:75–82. doi: 10.1111/j.1348-0421.2004.tb03490.x. [DOI] [PubMed] [Google Scholar]
- 11.Suzuki C, Kimoto-Nira H, Kobayashi M, Nomura M, Sasaki K, Mizumachi K. 2008. Immunomodulatory and cytotoxic effects of various Lactococcus strains on the murine macrophage cell line J774.1. Int J Food Microbiol 123:159–165. doi: 10.1016/j.ijfoodmicro.2007.12.022. [DOI] [PubMed] [Google Scholar]
- 12.Kimoto-Nira H, Mizumachi K, Okamoto T, Sasaki K, Kurisaki J. 2009. Influence of long-term consumption of a Lactococcus lactis strain on the intestinal immunity and intestinal flora of the senescence-accelerated mouse. Br J Nutr 102:181–185. doi: 10.1017/S0007114508143574. [DOI] [PubMed] [Google Scholar]
- 13.Eid J, Fehr A, Gray J, Luong K, Lyle J, Otto G, Peluso P, Rank D, Baybayan P, Bettman B, Bibillo A, Bjornson K, Chaudhuri B, Christians F, Cicero R, Clark S, Dalal R, Dewinter A, Dixon J, Foquet M, Gaertner A, Hardenbol P, Heiner C, Hester K, Holden D, Kearns G, Kong X, Kuse R, Lacroix Y, Lin S, Lundquist P, Ma C, Marks P, Maxham M, Murphy D, Park I, Pham T, Phillips M, Roy J, Sebra R, Shen G, Sorenson J, Tomaney A, Travers K, Trulson M, Vieceli J, Wegener J, Wu D, Yang A, Zaccarin D, Zhao P, Zhong F, Korlach J, Turner S. 2009. Real-time DNA sequencing from single polymerase molecules. Science 323:133–138. doi: 10.1126/science.1162986. [DOI] [PubMed] [Google Scholar]
- 14.Nakano K, Shiroma A, Shimoji M, Tamotsu H, Ashimine N, Ohki S, Shinzato M, Minami M, Nakanishi T, Teruya K, Satou K, Hirano T. 2017. Advantages of genome sequencing by long-read sequencer using SMRT technology in medical area. Hum Cell 30:149–161. doi: 10.1007/s13577-017-0168-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Nakano K, Shiroma A, Tamotsu H, Ohki S, Shimoji M, Ashimine N, Shinzato M, Minami M, Nakanishi T, Teruya K, Satou K, Suzuki C, Kimoto-Nira H, Kobayashi M, Mizumachi K, Aoki R, Miyata S, Yamamoto K, Ohtake Y, Eguchi-Ogawa T, Moriya N, Hagi T, Nomura M, Hirano T. 2016. First complete genome sequence of the skin-improving Lactobacillus curvatus strain FBA2, isolated from fermented vegetables, determined by PacBio single-molecule real-time technology. Genome Announc 4:e00884-16. doi: 10.1128/genomeA.00884-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Chin CS, Alexander DH, Marks P, Klammer AA, Drake J, Heiner C, Clum A, Copeland A, Huddleston J, Eichler EE, Turner SW, Korlach J. 2013. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods 10:563–569. doi: 10.1038/nmeth.2474. [DOI] [PubMed] [Google Scholar]